CV Sciences (CVSI) Capital Expenditures (2013 - 2026)
CV Sciences (CVSI) posted Capital Expenditures of $3000.0 for Q1 2026, down 66.67% sequentially from $9000.0 in Q4 2025, and down 92.5% YoY from $40000.0 in Q1 2025.
CV Sciences (CVSI) Capital Expenditures (2013 - 2026) Analysis & Trends
CV Sciences has reported Capital Expenditures for 12 years, with the latest figure at $3000.0 in Q1 2026.
- Quarterly Capital Expenditures fell 92.5% year-over-year to $3000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $72000.0 (up 24.14% YoY) and the FY2025 annual result came in at $109000.0, up 505.56% from the prior year.
- Capital Expenditures eased to $3000.0 in Q1 2026 per CVSI's latest filing, from $9000.0 in the prior quarter.
- Over five years, Capital Expenditures peaked at $49000.0 in Q2 2025 and troughed at $3000.0 in Q1 2026.
- A 3-year average of $21666.7 and a median of $14500.0 in 2024 frame the typical range for Capital Expenditures.
- The sharpest annual moves came in 2025 and 2026: Capital Expenditures plunged 50.0% in 2025, then slumped 92.5% in 2026.
- Over 3 years, Capital Expenditures stood at $18000.0 in 2024, then slumped by 50.0% to $9000.0 in 2025, then slumped by 66.67% to $3000.0 in 2026.
- According to Business Quant data, Capital Expenditures over the past three periods registered $3000.0, $9000.0, and $11000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 104.00 Mn |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn | 117.00 Mn |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn | -337.60 Mn |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn | 108.00 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 52.80 Mn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | 7.80 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 33.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | CV Sciences | 4.10 Mn | 3.84 Mn | 1.45 Mn | 7,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 7,000.00 |
| Jun 30, 2026 | 7,000.00 |
| Mar 31, 2026 | 3,000.00 |
| Mar 31, 2026 | 3,000.00 |
| Dec 31, 2025 | 9,000.00 |
| Dec 31, 2025 | 9,000.00 |
| Sep 30, 2025 | 11,000.00 |
| Sep 30, 2025 | 11,000.00 |
| Jun 30, 2025 | 49,000.00 |
| Jun 30, 2025 | 49,000.00 |
| Mar 31, 2025 | 40,000.00 |
| Mar 31, 2025 | 40,000.00 |
| Dec 31, 2024 | 18,000.00 |
| Dec 31, 2024 | 18,000.00 |
| Mar 31, 2021 | 35,000.00 |
| Mar 31, 2021 | 35,000.00 |
| Dec 31, 2020 | 818,000.00 |
| Dec 31, 2020 | 818,000.00 |
| Sep 30, 2020 | -267,000.00 |
| Sep 30, 2020 | -267,000.00 |